Qi, Shenggui
Li, Li
Yan, Yuhua
Gengdeng,
Ma, Xiaofeng
Yang, Airong
Fan, Hongguang
Article History
Received: 24 June 2025
Accepted: 12 November 2025
First Online: 29 December 2025
Declarations
:
: This study has been approved by the Medical Ethics Committee of Qinghai Cardio-Cerebrovascular Specialty Hospital, with the ethics approval number [qxll-2018-012]. All study procedures were conducted in accordance with the Declaration of Helsinki and the relevant regulations on ethical review of human biomedical research in China. A written informed consent process was adopted in this study, where the study protocol and consent form were prepared in Chinese. Since non-Han participants were all proficient in Chinese, all participants fully understood the study’s purpose, content, potential risks, and their rights after receiving explanations. All participants signed the informed consent form prior to their participation in the study.
: Not Applicable.
: The authors declare no competing interests.